pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,972 catalysts · 4,970 phase readout · 2,357 8k filing · 287 earnings · 276 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 28 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: phase readout×type: grant×clear all
type
  • phase readout4,970
  • 8k filing2,357
  • earnings287
  • pdufa276
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›TERMINATEDphase readoutNCT04030559: Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

    Sponsor: University of California, Davis. Phase: PHASE2. Conditions: ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, CDK12 Gene Mutation, CHEK1 Gene Mutation, CHEK2 Gene Mutation, DNA Damage Response Gene Mutation, DNA Repair Gene Mutation, FANCA Gene Mutation, FANCD2 Gene Mutation, FANCL Gene Mutation, GEN1 Gene Mutation, NBN Gene Mutation, Prostate Carcinoma, RAD51 Gene Mutation, RAD51C Gene Mutation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05398380: Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

    Sponsor: Hospital Vall d'Hebron. Phase: NA. Conditions: Colorectal Cancer, Liver Metastases, Genetic Change

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06713798: Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures

    Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: PHASE2. Conditions: Metastatic Cancer Lung, Advanced Lung Cancer, CBNPC Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06041763: Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Meniscus Tear

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07525063: Pain & Reward Neuromodulation of CNS Circuits

    Sponsor: Duke University. Phase: NA. Conditions: Fibromyalgia Syndrome, Fibromyalgia, Chronic Pain and Fatigue

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06501963: Revealing Protective Immunity to Influenza Using Systems Immunology

    Sponsor: Emory University. Phase: PHASE4. Conditions: Influenza

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06982521: Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

    Sponsor: Relay Therapeutics, Inc.. Phase: PHASE3. Conditions: PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06868979: Optical Imaging in X-linked Disorders.

    Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Fragile X Syndrome (FXS), Creatine Transporter Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04016246: Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation.

    Sponsor: University Hospital, Grenoble. Phase: PHASE3. Conditions: Respiratory Distress Syndrome in Premature Infant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05236062: Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

    Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07557446: A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)

    Sponsor: Angitia Biopharmaceuticals Guangzhou Limited. Phase: PHASE2. Conditions: Osteogenesis Imperfecta (OI)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07236099: Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

    Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.. Phase: PHASE2. Conditions: Prurigo Nodularis (PN)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06641999: Evaluating How a Tinnitus Implant Affects Tinnitus Loudness in Adults With Chronic Tinnitus and Varying Levels of Hearing Loss

    Sponsor: Cochlear. Phase: NA. Conditions: Tinnitus, Hearing Loss, Bilateral or Unilateral, Normal Hearing

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06620432: High vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean

    Sponsor: Fundacion Clinica Valle del Lili. Phase: NA. Conditions: Placenta Accreta Spectrum

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07568132: Efferon LPS Hemoadsorption in in Patients With Thermal Burns

    Sponsor: Efferon JSC. Phase: NA. Conditions: Burns

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04216732: Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Advanced Thyroid Gland Medullary Carcinoma, Stage III Thyroid Gland Medullary Carcinoma AJCC v8, Stage IV Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07704398: Effect of Corticosteroid Injection in Symptomatic Pulpitis Cases

    Sponsor: Istanbul Medipol University Hospital. Phase: NA. Conditions: Periapical Periodontitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07707063: This a Clinical Trial to Evaluate the Efficacy of I-PRF, Povidone-Iodine and Laser as Adjuncts to Non-surgical Periodontal Treatment in Smokers and Non-Smokers Periodontitis Patients

    Sponsor: Military Hospital of Tunis. Phase: PHASE4. Conditions: Periodontitis, Smokers, Non Smokers, Periodontal Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06954363: Effectiveness of Muscle Energy Techniques and Mulligan Mobilization Along With Conventional Physical Therapy in Knee Joint Osteoarthritis Patients

    Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Knee Osteoarthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07649187: Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG

    Sponsor: Ming-Hsing Chang. Phase: NA. Conditions: Myasthenia Gravis, Depression, Thymoma, Depression and Quality of Life, Quality of Life, Activities of Daily Living

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06100146: Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls

    Sponsor: University Ghent. Phase: NA. Conditions: Folate Deficiency, Vitamin B 12 Deficiency, Anemia, Megaloblastic, Cognitive Development, Depressive Symptoms

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07309146: Single-center Evaluation of Human Milk Quantity and Quality Over Five Years

    Sponsor: Charles University, Czech Republic. Phase: . Conditions: Lactating Women - Human Milk Donors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05080946: Using Aspirin to Improve Immunological Features of Ovarian Tumors

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: EARLY_PHASE1. Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04332146: Mindfulness-based Intervention for Postnatal Depression

    Sponsor: The University of Hong Kong. Phase: NA. Conditions: Postnatal Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06254846: Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).

    Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Uterine Cervical Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06671379: A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC

    Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07100379: Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study

    Sponsor: Boston Children's Hospital. Phase: NA. Conditions: Esophageal Atresia With Tracheo-esophageal Fistula, Esophageal Atresia, Esophageal Strictures

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06373679: Switch or Quit R01

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Cigarette Smoking, Smoking Behaviors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02697396: Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: HPV Vaccination

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07656662: Comparison of Split Box and Split Bone Block Techniques in Horizontal Ridge Augmentation

    Sponsor: Marmara University. Phase: . Conditions: Horizontal Alveolar Ridge Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04090762: Improving Perinatal Outcomes Using Conditional and Targeted Transfers

    Sponsor: RAND. Phase: NA. Conditions: Utilization, Health Care, Birth Outcomes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06723509: Description of Patient Adherence to Heart Failure Remote Monitoring and Its Determinants

    Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: . Conditions: Remote Monitoring, Heart Failure Patients

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03222609: A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

    Sponsor: AbbVie. Phase: PHASE2. Conditions: Myelofibrosis (MF)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07653932: Perioperative Quantitative Sensory Testing and Incision Pain Mapping in Thoracic Surgery

    Sponsor: Tongji Hospital. Phase: . Conditions: Postoperative Pain, Chronic Postsurgical Pain, Thoracic Surgery, Lung Resection, Mechanical Hyperalgesia, Central Sensitization

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07244263: A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

    Sponsor: Takeda. Phase: PHASE2. Conditions: Hidradenitis Suppurativa

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05826379: Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife

    Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Physical Inactivity, Walking, Cognitive Health, Self-regulation, Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07687979: Mobile Application for Gait Training in Parkinson's Disease

    Sponsor: Ege University. Phase: NA. Conditions: PARKINSON DIS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07128446: COPM-Based Goal Setting Strategies in the PICU

    Sponsor: Samsung Medical Center. Phase: NA. Conditions: Critical Illness, Pediatric Intensive Care Unit

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07709546: Closed Incision NPWT to Prevent Wound Complications Post-ECMO

    Sponsor: St. Antonius Hospital. Phase: NA. Conditions: ExtraCorporeal Membrane Oxygenation (ECMO), Wound Complications, Surgical Site Infection (SSI)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06540079: BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

    Sponsor: Biotronik, Inc.. Phase: NA. Conditions: Sinus Node Dysfunction, Bradycardia, Atrioventricular Block

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07395479: A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Advanced Malignant Tumours

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06386796: Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients

    Sponsor: Aswan University. Phase: . Conditions: Acute Kidney Injury, Critical Illness

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06702579: Home Monitoring in Hemophilia A

    Sponsor: Radboud University Medical Center. Phase: . Conditions: Hemophilia A, Anticoagulant Therapy, Monitoring, Point of Care Testing, Qualitative Research

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05067179: Analysis of Human ALS Tissues and Registry of ALS Patients

    Sponsor: University of Illinois at Chicago. Phase: . Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05318196: Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Acute Kidney Injury, Chronic Kidney Diseases, Solid-organ Transplantation, Cancer, Metabolic Disease, Immune Diseases

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07274579: An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Digestive Oncology

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05212428: DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Genetic Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07310628: Comparison of Analgesic Efficacy of Intrathecal Levobupivacaine With and Without Oral Tizanidine in Lower Limb Surgeries: A Prospective Randomized Study

    Sponsor: All India Institute of Medical Sciences. Phase: PHASE4. Conditions: Tizanididne, Levobupicaine, Lower Limb Surgery, Pain, Chronic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04052828: Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)

    Sponsor: Dr Erin Perrone. Phase: NA. Conditions: Congenital Diaphragmatic Hernia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07250828: Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy

    Sponsor: TriCity Research Center. Phase: NA. Conditions: Painful Diabetic Neuropathy (PDN), Diabetic Neuropathy, Neuropathic Pain, Chronic Pain

    full page →ctgov ↗
    ← prev
    page 90 of 100
    next →